Literature DB >> 34987210

Omicron's feeble attack on the lungs could make it less dangerous.

Max Kozlov.   

Abstract

Entities:  

Keywords:  SARS-CoV-2; Virology

Mesh：

Substances：

Year:  2022        PMID： 34987210     DOI： 10.1038/d41586-022-00007-8

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  25 in total

Review 1.  Roles of Sialyl Glycans in HCoV-OC43, HCoV-HKU1, MERS-CoV and SARS-CoV-2 Infections.

Authors:  Nongluk Sriwilaijaroen; Yasuo Suzuki
Journal:  Methods Mol Biol       Date:  2022

Review 2.  Immune response in COVID-19: what is next?

Authors:  Qing Li; Ying Wang; Qiang Sun; Jasmin Knopf; Martin Herrmann; Liangyu Lin; Jingting Jiang; Changshun Shao; Peishan Li; Xiaozhou He; Fei Hua; Zubiao Niu; Chaobing Ma; Yichao Zhu; Giuseppe Ippolito; Mauro Piacentini; Jerome Estaquier; Sonia Melino; Felix Daniel Weiss; Emanuele Andreano; Eicke Latz; Joachim L Schultze; Rino Rappuoli; Alberto Mantovani; Tak Wah Mak; Gerry Melino; Yufang Shi
Journal:  Cell Death Differ       Date:  2022-05-17       Impact factor: 12.067

3.  Modeling Incorporating the Severity-Reducing Long-term Immunity: Higher Viral Transmission Paradoxically Reduces Severe COVID-19 During Endemic Transition.

Authors:  Hyukpyo Hong; Ji Yun Noh; Hyojung Lee; Sunhwa Choi; Boseung Choi; Jae Kyoung Kim; Eui-Cheol Shin
Journal:  Immune Netw       Date:  2022-05-18       Impact factor: 5.851

4.  Oral antivirals for the prevention and treatment of SARS-CoV-2 infection.

Authors:  Vicente Soriano; Carmen de-Mendoza; Benson Edagwa; Ana Treviño; Pablo Barreiro; José V Fernandez-Montero; Howard E Gendelman
Journal:  AIDS Rev       Date:  2022-03-01       Impact factor: 2.381

Review 5.  The COVID-19 pandemic - what have urologists learned?

Authors:  Benedikt Ebner; Yannic Volz; Jan-Niclas Mumm; Christian G Stief; Giuseppe Magistro
Journal:  Nat Rev Urol       Date:  2022-04-13       Impact factor: 14.432

Review 6.  Emergence of SARS-CoV-2 Omicron (B.1.1.529) variant, salient features, high global health concerns and strategies to counter it amid ongoing COVID-19 pandemic.

Authors:  Rekha Khandia; Shailja Singhal; Taha Alqahtani; Mohammad Amjad Kamal; Nahed A El-Shall; Firzan Nainu; Perumal Arumugam Desingu; Kuldeep Dhama
Journal:  Environ Res       Date:  2022-01-29       Impact factor: 8.431

Review 7.  Omicron Genetic and Clinical Peculiarities That May Overturn SARS-CoV-2 Pandemic: A Literature Review.

Authors:  Giorgio Tiecco; Samuele Storti; Melania Degli Antoni; Emanuele Focà; Francesco Castelli; Eugenia Quiros-Roldan
Journal:  Int J Mol Sci       Date:  2022-02-11       Impact factor: 5.923

8.  Shorter serial intervals in SARS-CoV-2 cases with Omicron BA.1 variant compared with Delta variant, the Netherlands, 13 to 26 December 2021.

Authors:  Jantien A Backer; Dirk Eggink; Stijn P Andeweg; Irene K Veldhuijzen; Noortje van Maarseveen; Klaas Vermaas; Boris Vlaemynck; Raf Schepers; Susan van den Hof; Chantal Bem Reusken; Jacco Wallinga
Journal:  Euro Surveill       Date:  2022-02

Review 9.  Nanoparticle Delivery Platforms for RNAi Therapeutics Targeting COVID-19 Disease in the Respiratory Tract.

Authors:  Yuan Zhang; Juhura G Almazi; Hui Xin Ong; Matt D Johansen; Scott Ledger; Daniela Traini; Philip M Hansbro; Anthony D Kelleher; Chantelle L Ahlenstiel
Journal:  Int J Mol Sci       Date:  2022-02-22       Impact factor: 5.923

10.  SARS-CoV-2 Omicron variant is spreading in different parts of the world in three different trends.

Authors:  Perumal A Desingu; K Nagarajan
Journal:  J Med Virol       Date:  2022-02-08       Impact factor: 2.327
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.